Ryan Cohlhepp sold $288K of Bicara Therapeutics (BCAX)

Executed Apr 15, disclosed Apr 17, 2 days later.

Value, as filed

$288K

12,500 sh across 2 lots

Executed

Apr 15

the trade date, as filed

Disclosed

Apr 17

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Ryan Cohlhepp President, COO & Interim CEO profile →

Ryan Cohlhepp (President, COO & Interim CEO) filed 9 Form 4 reports in the trailing twelve months (0 purchases, 9 sales), most often in Bicara Therapeutics Inc. (BCAX). The largest single filing was $785K of BCAX (27,139 sh across 2 lots, as filed), executed Jul 8.

The name

BCAX

Bicara Therapeutics Inc. BCAX · Healthcare · 40 filings in 24 months ticker →

Healthcare · Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Ryan Cohlhepp in BCAX

BCAXSALE Bicara Therapeutics Inc. $320K
14,058 sh × $22.77
Exec Sep 8
Filed Sep 10 · 4:23 PM ET BCAXSALE Bicara Therapeutics Inc. $525K
18,750 sh × $27.98
Exec Aug 10
Filed Aug 12 · 4:19 PM ET BCAXSALE Bicara Therapeutics Inc. $785K
27,139 sh across 2 lots
Exec Jul 8
Filed Jul 10 · 4:10 PM ET BCAXSALE Bicara Therapeutics Inc. $162K
8,000 sh × $20.29
Exec May 15
Filed May 18 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $157K
8,000 sh × $19.66
Exec Mar 16
Filed Mar 17 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $234K
12,892 sh × $18.16
Exec Mar 3
Filed Mar 5 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $149K
8,000 sh × $18.68
Exec Dec 15 2025
Filed Dec 16 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. $144K
8,000 sh × $18.05
Exec Nov 21 2025
Filed Nov 25 2025 · 5:30 PM ET